Compare KARD & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KARD | JBLU |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Air Freight/Delivery Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2026 | 2002 |
| Metric | KARD | JBLU |
|---|---|---|
| Price | $20.10 | $4.85 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $4.91 |
| AVG Volume (30 Days) | 215.1K | ★ 24.3M |
| Earning Date | N/A | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 27.83 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $9,062,000,000.00 |
| Revenue This Year | N/A | $12.11 |
| Revenue Next Year | N/A | $6.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.58 | $3.87 |
| 52 Week High | $27.00 | $6.62 |
| Indicator | KARD | JBLU |
|---|---|---|
| Relative Strength Index (RSI) | 45.82 | 38.17 |
| Support Level | $19.67 | $4.55 |
| Resistance Level | $23.02 | $5.07 |
| Average True Range (ATR) | 1.40 | 0.20 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 23.97 | 16.99 |
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.